XSWX
SOON
Market cap16bUSD
Sep 17, Last price
235.00CHF
1D
1.12%
1Q
21.64%
Jan 2017
91.71%
IPO
88.80%
Name
Sonova Holding AG
Chart & performance
P/E
32.42
P/S
3.87
EPS
7.25
Div yield, %
1.87%
Shrs. gr., 5y
-0.87%
Rev. gr., 5y
6.74%
Revenues
3.61b
-0.19%
Net income
431m
-20.33%
CFO
684m
-13.81%
Dividend
Jun 19, 20264.7 CHF/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova's extensive offerings include advanced wireless communication devices, rechargeable hearing aids, wireless headsets, speech-enhanced hearables, premium audiophile headphones, microphones, and wireless transmission systems, alongside comprehensive audiological care services. Its renowned hearing aid brands comprise Phonak, Unitron, and Hansaton, while Advanced Bionics is its flagship for cochlear implants. For consumer audio, Sonova offers products under the Sennheiser brand. The company delivers its audiological care through a vast network of around 3,600 clinics and stores operating under various regional names such as AudioNova, Audium, and Boots Hearingcare, among others. Additionally, its products are distributed via independent partners. Sonova boasts a significant international presence, serving markets across the United States, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1947, the company was formerly known as Phonak Holding AG before officially changing its name to Sonova Holding AG in August 2007.
Related entities
Subsidiaries (6)
Advanced Bionics AG
Sonova AG
Sonova Audiological Care Austria GmbH
SONOVA BELGIUM
SONOVA RETAIL BELGIUM
SONOVA AUDIOLOGICAL CARE FRANCE SAS
Key people
Group Vice President Cochlear Implants, President of Advanced Bionics, Member of the Management Board · since 2019
Martin Grieder
Group Vice President Hearing Instruments Marketing, Member of the Management Board · since 2016
Claude Diversi
Group Vice President Hearing Instruments Wholesale, Member of the Management Board · since 2016
Hartwig Grevener
Member of the Management Board, Chief Financial Officer · since 2012
Non-Executive Independent Vice Chairman of the Board · since 2012
Non-Executive Independent Chairman of the Board · since 2011
Non-Executive Independent Director · since 2013
Headquarters & legal address
Laubisrütistrasse 28
Stäfa, ZH 8712
CH
Stäfa, ZH 8712
CH
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||